PRKAR1B (Protein Kinase A Regulatory Subunit 1 Beta) encodes the beta isoform of the type I regulatory subunit of cAMP-dependent protein kinase (PKA), a crucial enzyme in cellular signal transduction that plays essential roles in neuronal function, synaptic plasticity, learning, memory, and behavior. PKA is one of the most important downstream effectors of the cAMP second messenger pathway, and the regulatory subunits determine the subcellular localization, anchoring, and activation kinetics of the catalytic subunits. In the brain, PRKAR1B is predominantly expressed in neurons where it targets PKA to specific subcellular compartments including dendritic spines, synapses, and the nucleus, enabling precise temporal and spatial control of phosphorylation events that regulate synaptic strength, gene transcription, and ultimately cognitive function 1.
| PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta | |
|---|---|
| Gene Symbol | PRKAR1B |
| Full Name | Protein Kinase A Regulatory Subunit 1 Beta |
| Chromosome | 7p22.1 |
| NCBI Gene ID | 5577 |
| Ensembl ID | ENSG00000188191 |
| OMIM | 176911 |
| UniProt ID | P31321 |
| Protein Class | cAMP-Dependent Protein Kinase Regulatory Subunit |
| Tissue Expression | [Hippocampus](/brain-regions/hippocampus), Cerebral Cortex, Cerebellum, Striatum, Peripheral neurons |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Bipolar Disorder, Spinocerebellar Ataxia, Intellectual Disability |
The PRKAR1B gene is located on chromosome 7p22.1 and spans approximately 25 kb. It consists of 11 exons encoding a 415-amino acid protein with a molecular weight of approximately 46 kDa 2. The gene promoter contains multiple regulatory elements including cAMP response elements (CRE), allowing for transcription in response to cAMP signaling—a classic positive feedback mechanism in PKA regulation.
PRKAR1B has a modular architecture characteristic of PKA regulatory subunits:
N-terminal Dimerization Domain (aa 1-60): Forms the dimerization interface for regulatory subunit dimerization, creating the holoenzyme structure (R₂C₂). This domain contains the A-kinase anchoring protein (AKAP) binding motif.
Hinge Region (aa 61-100): Flexible linker connecting the dimerization and dimerization/docking (D/D) domain to the rest of the protein.
cAMP-Binding Domain A (aa 101-200): First cAMP-binding pocket (A-domain). Two cAMP molecules bind sequentially with positive cooperativity.
cAMP-Binding Domain B (aa 201-320): Second cAMP-binding pocket (B-domain). The tandem cAMP-binding domains give regulatory subunits high affinity for cAMP.
C-terminal Domain (aa 321-415): Contains the catalytic subunit interaction site and the autoinhibitory sequence that blocks activity in the holoenzyme state.
PKA exists as a tetramer:
In the inactive state, the regulatory subunits hold the catalytic subunits in an inactive conformation. cAMP binding causes a conformational change that releases the catalytic subunits, allowing them to phosphorylate substrates.
PRKAR1B exhibits distinctive expression in the nervous system:
| Region | Expression Level | Cellular Localization |
|---|---|---|
| Hippocampus | Very High | CA1/CA3 pyramidal cells, dentate granule cells |
| Cerebral Cortex | High | Layer V pyramidal neurons |
| Cerebellum | High | Purkinje cells |
| Striatum | High | Medium spiny neurons |
| Brainstem | Moderate | Various nuclei |
| Spinal Cord | Moderate | Motor neurons |
In neurons, PRKAR1B is targeted to:
The PRKAR1 gene produces multiple isoforms:
Second Messenger Generation: G-protein-coupled receptors (GPCRs) activate adenylate cyclase, producing cAMP from ATP.
cAMP Binding: Four cAMP molecules bind to the regulatory subunit dimer (two per R subunit), causing conformational change.
Catalytic Subunit Release: Activated catalytic subunits are released and can phosphorylate substrates.
Substrate Phosphorylation: Targets include ion channels, receptors, transcription factors, and metabolic enzymes.
Signal Termination: Phosphodiesterases (PDEs) degrade cAMP; protein phosphatases remove phosphate groups.
PRKAR1B is anchored to specific subcellular locations by A-kinase anchoring proteins (AKAPs):
| AKAP | Location | Function |
|---|---|---|
| AKAP5 (AKAP75/79) | Postsynaptic density | LTP/LTD, AMPA trafficking |
| AKAP6 (AKAP150/200) | Dendritic spines | Synaptic plasticity |
| AKAP1 (D-AKAP) | Mitochondria | Metabolic regulation |
| AKAP3 | Sperm/neurons | Unknown in brain |
AKAP-mediated targeting enables spatially restricted PKA signaling 3.
PKA signaling is critically impaired in AD:
PKA is essential for LTP:
PKA also mediates LTD:
The cAMP-PKA-CREB pathway is critical:
| Variant | Effect | Disease |
|---|---|---|
| Promoter variants | Altered expression | Bipolar disorder |
| Coding variants | Altered function | Ataxia, intellectual disability |
| eQTL variants | Expression changes | AD, PD |
| Drug | Target | Development Status |
|---|---|---|
| Rolipram | PDE4 | Clinical trials for AD |
| Sildenafil | PDE5 | Cognitive enhancement |
| Ibudilast | PDE3/4 | Neuroprotection |
Scott JD (2006). Compartmented cAMP signalling. Nature Reviews Molecular Cell Biology
Kandel ES, et al. (2001). Molecular basis of PKA function. Cellular and Molecular Neurobiology
Wong W, Scott JD (2004). AKAP signaling complexes. Nature Reviews Molecular Cell Biology
Houslay MD, et al. (2007). PDE4 cAMP phosphodiesterases. Nature Reviews Drug Discovery
Sindreu CB, et al. (2007). cAMP-PKA in memory. Learning and Memory
Brandon EP, et al. (1997). PKA and learning. Current Opinion in Neurobiology
Nishi A, et al. (2008). DARPP-32 and PKA. Nature Reviews Neuroscience
Matsumoto K, et al. (2001). PRKAR1B in neurons. Journal of Neurochemistry
Barco A, et al. (2002). cAMP response elements in memory. Nature Reviews Neuroscience
Johannessen M, et al. (2003). PKA and gene transcription. Cell Signal
Bhattacharyya R, et al. (2021). PKA in AD. Journal of Alzheimer's Disease
Yuan HD, et al. (2020). cAMP-PKA in neurodegeneration. Neuropharmacology
Zhang G, et al. (2021). PDE inhibitors in AD. Alzheimer's and Dementia
Berman DE, et al. (2007). AKAP in synaptic plasticity. Nature Reviews Neuroscience
Weber IT, et al. (2006). PKA structure. Advances in Pharmacology
Taylor SS, et al. (2005). PKA catalytic subunit. Annual Review of Biochemistry
Lee YI, et al. (2009). PRKAR1B expression in brain. Neuroscience Letters
Bollen M, et al. (2010). PP1 and PP2A in neurons. Nature Reviews Neuroscience